These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26708309)

  • 21. High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.
    de Souza AW; Perazzio SF; de França NR; Andrade LE; Bijl M; Westra J; Kallenberg CG
    Rheumatology (Oxford); 2015 Dec; 54(12):2151-5. PubMed ID: 26170374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
    Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
    Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum YKL-40 as a marker of disease activity and stricture formation in patients with Crohn's disease.
    Erzin Y; Uzun H; Karatas A; Celik AF
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e357-62. PubMed ID: 17725598
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum YKL-40 is a reliable biomarker for pulmonary alveolar proteinosis.
    Bonella F; Long X; He X; Ohshimo S; Griese M; Guzman J; Costabel U
    Respirology; 2017 Oct; 22(7):1371-1378. PubMed ID: 28569052
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum levels of alpha-1 acid glycoprotein and pentraxin 3 in patients with Behçet's disease and relationship with disease activity.
    Yazmalar L; Batmaz İ; Sula B; Alpaycı M; Aydın F; Türkçü F; Yıldız M; Kaplan İ; Bozkurt M; Dağlı AZ; Burkan YK; Sarıyıldız MA
    Int J Dermatol; 2015 Oct; 54(10):e394-400. PubMed ID: 26147939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behçet's disease.
    Evereklioglu C; Er H; Türköz Y; Cekmen M
    Mediators Inflamm; 2002 Apr; 11(2):87-93. PubMed ID: 12061429
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum YKL-40 as a potential biomarker of inflammation in psoriasis.
    Baran A; Myśliwiec H; Szterling-Jaworowska M; Kiluk P; Świderska M; Flisiak I
    J Dermatolog Treat; 2018 Feb; 29(1):19-23. PubMed ID: 28498006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum YKL-40 in psoriasis with and without arthritis; correlation with disease activity and high-resolution power Doppler ultrasonographic joint findings.
    Ahmed SF; Attia EA; Saad AA; Sharara M; Fawzy H; El Nahrery EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):682-8. PubMed ID: 25087779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High YKL-40 serum levels and its expression in the muscle tissues of patients with antisynthetase syndrome.
    Carboni RCS; Behrens Pinto GL; Shinjo SK
    Adv Rheumatol; 2021 Jul; 61(1):44. PubMed ID: 34225813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of Endocan Serum Level in Patients with Behçet Disease: Relation to Disease Activity and Carotid Intima Media Thickness.
    Hassan WA; Behiry EG; Abdelshafy S; Salem T; Baraka EA
    Egypt J Immunol; 2020 Jan; 27(1):129-139. PubMed ID: 33180395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early detection and prognosis of ovarian cancer using serum YKL-40.
    Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
    J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel inflammatory marker in dialysis patients: YKL-40.
    Okyay GU; Er RE; Tekbudak MY; Paşaoğlu Ö; Inal S; Öneç K; Paşaoğlu H; Altok K; Derici Ü; Erten Y
    Ther Apher Dial; 2013 Apr; 17(2):193-201. PubMed ID: 23551676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitinase-3-like protein 1 levels in bipolar disorder.
    Sahin B; Inanli I; Calıskan AM; Uysal S
    Saudi Med J; 2019 Jan; 40(1):26-32. PubMed ID: 30617377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum substance P and calcitonin gene-related peptide levels in Behçet's disease and their association with disease activity.
    Aki T; Karincaoglu Y; Seyhan M; Batcioglu K
    Clin Exp Dermatol; 2006 Jul; 31(4):583-7. PubMed ID: 16716167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum YKL-40 as predictor of outcome in hypersensitivity pneumonitis.
    Long X; He X; Ohshimo S; Griese M; Sarria R; Guzman J; Costabel U; Bonella F
    Eur Respir J; 2017 Feb; 49(2):. PubMed ID: 27836954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum YKL-40 in coronary heart disease: linkage with inflammatory cytokines, artery stenosis, and optimal cut-off value for estimating major adverse cardiovascular events.
    Song M; Zhang G; Shi H; Zhu E; Deng L; Shen H
    Front Cardiovasc Med; 2023; 10():1242339. PubMed ID: 38028459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
    Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children.
    Kyrgios I; Galli-Tsinopoulou A; Stylianou C; Papakonstantinou E; Arvanitidou M; Haidich AB
    Metabolism; 2012 Apr; 61(4):562-8. PubMed ID: 22036069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure.
    Bilim O; Takeishi Y; Kitahara T; Ishino M; Sasaki T; Suzuki S; Shishido T; Kubota I
    J Card Fail; 2010 Nov; 16(11):873-9. PubMed ID: 21055651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum levels of GRO-α are elevated in association with disease activity in patients with Behçet's disease.
    Kato Y; Yamamoto T
    Int J Dermatol; 2012 Mar; 51(3):286-9. PubMed ID: 22348563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.